683 Capital Management, LLC

Source: SEC Form 13F · as of Mar 2026

683 Capital Management, LLC holds 80 biotech & pharma companies tracked by BioSniper, totaling $692.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

80

Total value held

$692.9M

CompanySharesValue
LLYELI LILLY & Co149,000$137.0M
ALNYALNYLAM PHARMACEUTICALS, INC.149,100$49.3M
MDGLMADRIGAL PHARMACEUTICALS, INC.90,000$47.1M
PTGXProtagonist Therapeutics, Inc370,100$39.0M
PRAXPraxis Precision Medicines, Inc.112,700$36.3M
WVEWave Life Sciences Ltd.4,900,000$35.5M
ANABANAPTYSBIO, INC625,000$34.7M
QUREuniQure N.V.1,753,600$28.7M
AMLXAmylyx Pharmaceuticals, Inc.1,626,600$22.6M
MOHMolina Healthcare Inc160,000$21.3M
MGTXMeiraGTx Holdings plc2,450,000$21.2M
PHATPhathom Pharmaceuticals, Inc.1,850,000$20.6M
TGTXTG THERAPEUTICS, INC.590,000$19.6M
SRPTSarepta Therapeutics, Inc.750,000$16.3M
ELVElevance Health Inc.40,000$11.7M
FOLDAMICUS THERAPEUTICS, INC.775,000$11.2M
APLSApellis Pharmaceuticals, Inc.250,000$10.1M
INSMINSMED Inc60,000$9.8M
ZVRAZEVRA THERAPEUTICS, INC.975,000$9.1M
UNHUnitedHealth Group Incorporated Common Stock (DE)32,000$8.7M
MRNAModerna, Inc.156,000$7.9M
ALECAlector, Inc.3,200,000$6.9M
ICLRICON plc62,000$6.9M
VKTXViking Therapeutics, Inc.190,000$6.2M
NVONovo Nordisk A/S150,000$5.5M
RVMDREVOLUTION MEDICINES, INC.50,100$4.9M
TBPHTheravance Biopharma, Inc.250,000$4.1M
RNAAtrium Therapeutics Inc.300,000$4.0M
MREOMereo BioPharma Group plc12,000,000$4.0M
ABEOABEONA THERAPEUTICS INC.770,000$3.4M
IVVDInvivyd, Inc.2,515,000$3.3M
GUTSFractyl Health Inc.6,727,235$3.1M
IFRXInflaRx N.V.3,315,000$3.0M
ALDXAldeyra Therapeutics, Inc.1,500,000$2.5M
CNTBConnect Biopharma Holdings Ltd900,000$2.4M
IOVAIOVANCE BIOTHERAPEUTICS, INC.644,300$2.3M
RNACCartesian Therapeutics, Inc.330,000$2.0M
CTMXCytomX Therapeutics, Inc.425,000$2.0M
GOSSGossamer Bio, Inc.5,000,000$1.6M
MAIAMAIA Biotechnology, Inc.1,066,666$1.5M
ARMPArmata Pharmaceuticals, Inc.137,000$1.4M
PYXSPyxis Oncology, Inc.896,263$1.3M
MSLESatellos Bioscience Inc.230,833$1.3M
PMNProMIS Neurosciences Inc.92,850$1.2M
INABIN8BIO, INC.724,637$1.1M
SRZNSurrozen Inc.33,000$961K
ANROAlto Neuroscience, Inc.40,000$899K
AVTXAvalo Therapeutics, Inc.56,850$849K
CRBPCorbus Pharmaceuticals Holdings, Inc.85,543$803K
SRRKScholar Rock Holding Corp16,200$796K
IMRXImmuneering Corp150,697$794K
CCCCC4 Therapeutics, Inc.300,000$789K
OBIOOrchestra BioMed Holdings Inc.185,000$786K
ASMBASSEMBLY BIOSCIENCES, INC.27,863$773K
KYTXKyverna Therapeutics, Inc.85,000$734K
SGMTSagimet Biosciences Inc.126,349$660K
MODDModular Medical Inc.125,001$660K
ZURAZura Bio Ltd110,000$655K
VTVTvTv Therapeutics Inc.16,000$635K
CLYMClimb Bio, Inc.90,000$617K
CABACabaletta Bio, Inc.225,000$605K
ELTXElicio Therapeutics, Inc.56,442$603K
ACHVACHIEVE LIFE SCIENCES, INC.200,000$588K
BDTXBlack Diamond Therapeutics, Inc.247,958$528K
FBRXForte Biosciences, Inc.20,000$518K
CAMPCamp4 Therapeutics Corp108,000$476K
ALTSALT5 Sigma Corp410,000$455K
GALTGALECTIN THERAPEUTICS INC162,484$453K
ADMAADMA BIOLOGICS, INC.50,000$451K
INOINOVIO PHARMACEUTICALS, INC.248,790$433K
HRMYHarmony Biosciences Holdings, Inc.14,700$412K
MBOTMicrobot Medical Inc.170,000$410K
AGENAGENUS INC114,336$382K
RANIRani Therapeutics Holdings, Inc.487,168$358K
NTHINEONC TECHNOLOGIES HOLDINGS, INC.50,000$351K
COYACoya Therapeutics, Inc.70,000$276K
KLRSKalaris Therapeutics, Inc.45,000$260K
MDXHMDxHealth SA97,000$223K
GNLXGENELUX Corp60,000$145K
IMDXInsight Molecular Diagnostics Inc.29,000$95K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    683 Capital Management, LLC — Biotech 13F Holdings & Portfolio | BioSniper